Trials / Completed
CompletedNCT04383041
Study to Learn More About Outcomes Reported by Patients Suffering From Type 2 Diabetes Using a Digital Data Collection Tool
Digital Collected Patient Reported Outcomes in a Diabetes Cohort
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 32 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this study researchers want to gain more information on patients who are treated with Metformin for their Type 2 Diabetes. Adult female and male patients with a prescription of a Metformin containing drug will be invited to the study in a public pharmacy after the decision for treatment with Metformin has been made by the treating physician. The pharmacist will provide interested participants access to a special phone App and participants are asked to complete via this phone App a questionnaire on their health situation with special focus on their Type 2 Diabetes. This includes questions on complications and self-care activities in relation to their diabetes, questions on quality of life and health history. There will be no extra visit to the treating doctor or a pharmacy. The study is aiming to have the questionnaire completed by 300 participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | Completing questionnaires via ePRO app from their own mobile devices |
Timeline
- Start date
- 2020-07-02
- Primary completion
- 2020-12-09
- Completion
- 2021-01-27
- First posted
- 2020-05-11
- Last updated
- 2021-07-01
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT04383041. Inclusion in this directory is not an endorsement.